Solvay SA | Large-cap | Basic Materials

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 5.1B
Gross Profit 1.1B 22.34%
Operating Income 651.0M 12.69%
Net Income 233.0M 4.54%
EPS (Diluted) €2.10

Balance Sheet Metrics

Total Assets 6.7B
Total Liabilities 5.3B
Shareholders Equity 1.4B
Debt to Equity 3.77

Cash Flow Metrics

Operating Cash Flow 280.0M
Free Cash Flow 330.0M

Revenue & Profitability Trend

Solvay SA Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue5.1B6.0B8.0B11.4B9.7B
Cost of Goods Sold4.0B4.6B6.6B8.5B7.2B
Gross Profit1.1B1.4B1.4B2.9B2.5B
Operating Expenses491.0M573.0M440.0M1.5B1.5B
Operating Income651.0M803.0M805.0M1.2B844.0M
Pre-tax Income320.0M180.0M1.1B1.1B-844.0M
Income Tax87.0M208.0M228.0M110.0M248.0M
Net Income233.0M2.1B1.9B989.0M-929.0M
EPS (Diluted)€2.10€19.85€18.30€9.13-€9.32

Income Statement Trend

Solvay SA Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets2.5B2.7B7.0B6.8B4.5B
Non-Current Assets4.2B4.3B13.7B13.2B12.3B
Total Assets6.7B7.0B20.7B20.0B16.8B
Liabilities
Current Liabilities1.9B2.2B4.9B5.5B2.8B
Non-Current Liabilities3.4B3.5B5.1B5.7B6.7B
Total Liabilities5.3B5.7B10.0B11.2B9.5B
Equity
Total Shareholders Equity1.4B1.3B10.7B8.9B7.3B

Balance Sheet Composition

Solvay SA Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income233.0M2.1B1.9B989.0M-929.0M
Operating Cash Flow280.0M1.2B1.4B104.0M-795.0M
Investing Activities
Capital Expenditures-261.0M-960.0M-794.0M-531.0M-446.0M
Investing Cash Flow-286.0M-1.7B-730.0M-426.0M762.0M
Financing Activities
Dividends Paid-260.0M-424.0M-417.0M-431.0M-419.0M
Financing Cash Flow-228.0M-344.0M-1.0B-952.0M-1.5B
Free Cash Flow330.0M847.0M1.1B863.0M693.0M

Cash Flow Trend

Solvay SA Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 15.83
Forward P/E 7.23
Price to Book 2.26
Price to Sales 0.61
PEG Ratio 7.23

Profitability Ratios

Profit Margin 3.88%
Operating Margin 11.83%
Return on Equity 14.16%
Return on Assets 5.18%

Financial Health

Current Ratio 1.38
Debt to Equity 155.68
Beta 0.67

Per Share Data

EPS (TTM) €1.86
Book Value per Share €13.02
Revenue per Share €48.41

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
solb3.1B15.832.2614.16%3.88%155.68
Syneos Health 6.9B377.861.03-1.38%-1.59%28.51
Basilix Cert 3.7M--695.33%0.00%25.22
Anheuser-Busch InBev 120.4B21.061.576.60%11.75%81.53
Azelis Group NV 3.2B17.861.126.77%4.29%63.15
Titan Cement 2.9B9.971.4115.09%10.55%33.45

Financial data is updated regularly. All figures are in the company's reporting currency.